For the analysis as a whole, “The more localized the copper on an IUD frame and the ability of the frame to conform to the uterine cavity, the more favorable were outcomes at one year,” wrote the authors.
For younger women who use a copper intrauterine device (IUD), there are significant differences in continuation, reported undesirable effects, and estimated costs at 1 year, according to a secondary analysis of the European Active Surveillance Study for Intrauterine Devices (EURAS-IUD).1
The analysis in The European Journal of Contraception & Reproductive Health Care found that copper IUD users were greatly influenced by IUD type: surface area, shape or design, width, and arms' flexibility.
A total of 5,796 copper IUD users under the age of 30 were identified at EURAS-IUD study recruitment, of whom 99.4% users were evaluated.
Overall, 98% of IUDs were framed, with the Nova T380 being the most popular brand. In addition, 32% of all IUDs were T-shaped IUDs with a copper surface area of 380 mm2 and copper bands on their rigid transverse arms, thus encompassing “gold standard” IUDs like the CuT380A or TCu380A.
Higher IUD continuation, fewer unwanted effects, and lower costs were noted for IUDs of the lowest copper content (<300 mm2), horse-shoe frame design, widths 18 mm to <30 mm, and flexible IUD arms.
Conversely, discontinuation, unwanted effects, and costs were greater with frameless IUDs and framed IUDs that were ≥30mm wide with 380 mm2 of copper and copper bands on their rigid transverse IUD arms.
Continuation at 1 year was highest in those aged 25 to 29, users of IUDs containing <300 mm2 of copper, IUDs with copper only on the vertical stem or string, and IUDs with flexible arms.
However, continuation rates were not impacted by previous pregnancy or birth.
Overall, 35.4% of participants experienced unwanted effects during the first year of IUD use: bleeding (18.8%), pain (16.9%), expulsion (3.3%), pregnancy (1.0%), and perforation 6 (0.1%).
Unwanted effects were lowest for IUDs with <300 mm2 of copper,horse-shoe design, and widths 18 mm to < 24 mm, whereas users of IUDs that had 380 mm2 of copper, gold standard IUDs, and frameless IUDs were more likely to report unwanted effects.
In total, 25% of participants had visited a health care professional due to undesirable effects.
The lowest costs were associated with IUDs of copper content <300mm2, horse-shoe design, widths 18 mm to < 30mm, and with IUD arms that flex down.
In contrast, frameless IUDs had the highest costs. Amongst framed IUD types, gold standard IUDs were linked to the highest expense.
The incidence of pregnancies in the first year did not differ significantly between IUD type. Of the 59 pregnancies reported, 13% (n = 8) were ectopic pregnancies: 6 in the 25 to 29 age group and 2 in the 20 to 24 age group.
Five of the 8 ectopic pregnancies were among gold standard IUD users; 1 of the 8 in a user of a 380mm2 T-shaped without arm bands IUD; and the remaining2 using IUDs of copper content 300 mm2 to <380 mm2, horse-shoe design, width 18 mm to <24 mm, and IUD arms that flex down.
For the analysis as a whole, “The more localized the copper on an IUD frame and the ability of the frame to conform to the uterine cavity, the more favorable were outcomes at one year,” wrote the authors.
The authors said clinicians should consider the study’s findings when counseling and selecting IUD types for younger women.
__
Reference:
Recap on reproductive rights with David Hackney, MD, MS
December 20th 2022In this episode of Pap Talk, we spoke with David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of ACOG's Ohio chapter for a full recap of where restrictions on reproductive rights have been and where they're going.
Listen
CooperSurgical unveils new inserter for simplified Paragard IUD placement
September 4th 2024The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen
How the mifepristone case highlights the need to protect reproductive health care
August 13th 2024Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.
Read More